Serum Institute Of India As Covishield

Rediff.com » News » Serum Institute Of India As Covishield

News for Serum Institute Of India As Covishield

News
Business

Serum Institute defends Covishield pricing amid row

Serum Institute of India, which makes the most used COVID-19 vaccine in the country, on Saturday defended pricing Covishield vaccine at 1.5 times the initial rate, saying the earlier price was......

1st Covishield vaccines consignment leaves Serum Institute

A decisive phase in India's fight against coronavirus began in the wee hours on Tuesday as the first consignment of Covishield vaccines left Serum Institute of India for Pune airport, four days......

Serum Institute seeks regular marketing approval for Covishield

Pointing out that over 100 crore doses of Covishield have been supplied in India and many other countries, Serum Institute of India on Monday sought regular marketing approval for the COVID-19......

5 dead in Serum Institute fire; Covishield facility unaffected

Five men died after a fire broke out in a five-storeyed under-construction building in the Serum Institute of India's Manjri premises in Pune on Thursday, police said. IMAGE: Smoke billows......

As Covid cases rise, Serum Institute restarts manufacture of Covishield

Serum Institute of India CEO Adar Poonawalla on Wednesday said the company has restarted manufacturing of Covid-19 vaccine Covishield amid rising numbers of cases of the virus infection. IMAGE:......

Serum Institute to start phase-2 trials of Oxford-AstraZeneca vaccine

The institute expects to complete both, phase-2 and 3 trials in India by the end of this year. Pune's Serum Institute of India (SII) is all set to start phase-2 clinical trials of the Oxford......

Why Modi visited Serum's Covid vaccine unit

The PM's visit would signal a strong intent towards making sure India becomes a beneficiary as vaccines become a massively traded commodity in the coming years.Abhishek Waghmare and Sohini Das......

A new 'dawn': Serum vaccine shipment to start today

Stocks of Oxford COVID-19 vaccine, Covishield, are likely to start moving out of Serum Institute of India's facility here on early Tuesday morning, days ahead of the nationwide inoculation drive,......

Meet Adar Poonawala, India's COVID-19 vaccine man

Serum Institute is investing $200 million to create capacities for the COVID-19 vaccine.Sohini Das profiles its 39-year-old CEO. IMAGE: Adar Poonawalla, right, and his father Dr Cyrus S......

Serum Institute Of India As Covishield

News for Serum Institute Of India As Covishield

Serum Institute defends Covishield pricing amid row

1st Covishield vaccines consignment leaves Serum Institute

Serum Institute seeks regular marketing approval for Covishield

5 dead in Serum Institute fire; Covishield facility unaffected

As Covid cases rise, Serum Institute restarts manufacture of Covishield

Serum Institute to start phase-2 trials of Oxford-AstraZeneca vaccine

Why Modi visited Serum's Covid vaccine unit

A new 'dawn': Serum vaccine shipment to start today

Meet Adar Poonawala, India's COVID-19 vaccine man

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS